Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateCue Biopharma, Inc.
XNAS•Health Care•Pharmaceutical Preparations
Flagged at $22.50 at 08:39 AM on Oct 09, then ran to $29.00 +29% that session.
The high is the session peak after our first alert, not a realized trade. Not investment advice.
Why is CUE down today? It is at $18.78 (-0.90%), and our scanner flagged it 80 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment CUE spikes, and full due diligence on CUE — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $CUE 80 times in the last 30 days. Create a free account to track $CUE, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on CUE from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CUE today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystClinical / FDA update, from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Oct 15, 2026 · 7 days agoAcross every filing on file, supply equal to 48.4% of the tradeable float is in play - 48.4% more can still be issued.
Shelf sizes are dollars, so shares are estimated at today's price.
Active shelf on file — the company can issue new shares on demand (valid ~3 years)
About $50.0M in size
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Lin Shao-Lee Officer | Sold (automatic/other) | -11K 0.2% of company | sold 1.6% | 695K | $305K at $27.50 | Oct 12, 26 |
Meluzio Michael Vincent Officer | Sold (automatic/other) | -1K 0.02% of company | sold 2.3% | 48K | $32K at $28.05 | Oct 12, 26 |
Ray Sumita Officer | Sold (automatic/other) | -2K 0.03% of company | sold 1.6% | 117K | $52K at $28.05 | Oct 12, 26 |
Lin Shao-Lee Officer | Sold (automatic/other) | -18K 0.3% of company | sold 2.5% | 706K | $496K at $27.19 | Aug 13, 26 |
Meluzio Michael Vincent Officer | Sold (automatic/other) | -6K 0.08% of company | sold 10% | 49K | $165K at $29.37 | Aug 13, 26 |
Meluzio Michael Vincent Officer | Other | 14K 0.2% of company | added 33% | 55K | n/a | Aug 13, 26 |
Ray Sumita Officer | Sold (automatic/other) | -9K 0.1% of company | sold 6.9% | 119K | $259K at $29.37 | Aug 13, 26 |
Ray Sumita Officer | Other | 18K 0.3% of company | added 17% | 127K | n/a | Aug 13, 26 |
Lin Shao-Lee Officer | Sold (automatic/other) | -40K 0.6% of company | sold 5.2% | 724K | $1.1M at $26.99 | Aug 12, 26 |
Lin Shao-Lee Officer | Other | 109K 1.5% of company | added 17% | 764K | n/a | Aug 12, 26 |
Ahlers James M Officer | Acquired (grant/award) | +26K 0.4% of company | n/a | 26K | n/a | Jul 30, 26 |
Borie Dominique Christian Officer | Acquired (grant/award) | +32K 0.4% of company | n/a | 32K | n/a | Jul 13, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on CUE from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CUE today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
CUE last traded at $18.78, down 0.90% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Cue Biopharma, Inc. (CUE) is next expected to report earnings on Wednesday, November 11, 2026, about 20 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The CUE Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged CUE 80 times in the last 30 days.
CUE (Cue Biopharma, Inc.) trades on XNAS, with a market cap of about $138M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge CUE for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$CUE discussion
Sign in to ask a question or join the discussion.